Vedanta Fund Raise of ₹2,575 Cr

Vedanta Price Movement Clarification

Vedanta clarified the cancelled 28.8-acre parcel is under 1% of its Jharsuguda land, now pending VAML transfer. The company deemed the matter immaterial with no operational impact.

Vedanta Earnings Call Transcript: Key Takeaways

Vedanta delivered record revenue and EBITDA driven by operational execution and cost management post-demerger.

Vedanta Results Update

Vedanta files its Q2/H1 FY27 press release and investor presentation alongside board-approved results. The release reports record quarterly performance and declares a ₹5 per share interim dividend.

Zinc International MIC capacity

500 ktpa

Vedanta Q2 FY27 Results: Net Profit ₹6,202 Cr, Up 78.3% YoY

Vedanta Ltd reported revenue from operations of ₹26,356 Cr (+57.5% YoY) and net profit of ₹6,202 Cr (+78.3% YoY) for Q2 FY27.

Key figure

Net profit ₹6,202 Cr · +78.3% YoY

Vedanta Employee Stock Options

Vedanta's NRC approved 99,32,834 performance-based ESOPs under VEDL ESOS 2026. Options vest over 36 months at par value ₹1 per share.

Vedanta Other Announcement

Vedanta filed its Integrated Filing (Governance) for the quarter ended September 30, 2026, covering the Corporate Governance Report and investor complaints status. The filing is a routine compliance submission with no financial or business event.

Pajson Agro India Fund Raise of ₹354.5 Cr

Pajson Agro's board approved a Rs.354.52 Crore preferential issue of 1,20,58,397 equity shares at Rs.294 each. Shareholder approval is sought at a meeting on 04-12-2026.

Value

₹354.5 Cr

Evonile Pharma Fund Raise of ₹900 Cr

Evonile Pharma's board approved a partly paid rights issue of up to Rs 900 Crore. A committee will set the issue price, record date and entitlement.

Value

₹900.0 Cr

Lloyds Metals & Energy Fund Raise

Lloyds Metals and Energy's board approved a fund raise, with the mode of financing yet to be decided. Investors should watch for the eventual issuance structure and size.

Shlokka Dyes Fund Raise of ₹24.5 Cr

Shlokka Dyes board approved a ₹24.50 Crore preferential issue of equity shares and warrants. Shareholder approval is pending at a November 28, 2026 meeting.

Value

₹24.50 Cr

Crescentis Capital Fund Raise of ₹79.62 Cr

Crescentis Capital's board approved the Letter of Offer for a rights issue of 1,02,08,129 shares at Rs.78 each. The issue aggregates to Rs.7,962.34 lakhs, or about Rs.79.62 Crore, assuming full subscription.

Value

₹79.62 Cr

Execution

Issue opening November 16, 2026; closing November 27, 2026; listing on or about December 3, 2026

Acetech E-Commerce Fund Raise of ₹40 Cr

Acetech E-Commerce approved a ₹40 Crore Rights Issue and 70% acquisition of Unique Cookware (₹10.41 Crore). Both decisions will fund expansion into cookware and allied products.

Value

₹40.00 Cr